Abstract:Introduction Increasing evidence has shown that trefoil factor 3 (TFF3) is increased in expression in various cancers and promotes cancer progression. Elevated TFF3 levels have been reported in lung cancer patients. TFF3, which is expressed in the vast majority of lung adenocarcinomas (ADC), has also been proposed as a novel biomarker to distinguish between lung ADC and squamous-cell carcinoma (SCC). Herein, we investigated the oncogenic functions of TFF3 and explored the potential of therapeutic TFF3 inhibition in NSCLC. Material and methods The function of TFF3 in lung ADC was investigated by either forced or depleted expression of TFF3 in H1299 and H1975 cell lines. Cell functional assays performed include total cell count, PI-Annexin V apoptosis assay, cell cycle analysis, soft agar colony formation, 3Dgrowth in Matrigel, wound healing and transwell migration and invasion assays. A novel small molecule TFF3 inhibitor, AMPC, has been developed in and was used to examine the functional effects of TFF3 inhibition in the lung ADC cells, both as a single agent and in combination with MEK1/2 inhibitors. The paracrine effect of local TFF3 production by lung ADC cells on non-TFF3 expressing lung SCC cells was examined using co-culture assays. Results and discussions The forced expression of TFF3 enhanced cell proliferation and survival, increased anchorage-independent growth, and promoted cell migration and invasion in lung ADC cells. In contrast, the siRNA-mediated depletion of TFF3 expression decreased the oncogenicity of these cells. Consistently, the inhibition of TFF3 by AMPC resulted in markedly decreased cell survival, proliferation, 3D growth and foci formation of lung ADC cells. Expression of the proto-oncogene ARAF was increased by forced expression of TFF3 in lung ADC cells, with consequent increased activation of downstream MEK1/2 and ERK1/2. This TFF3-mediated activation of the MAPK/ERK pathway was required for TFF3-stimulated 3D-growth of lung ADC cells. Moreover, the combination of MEK1/2 inhibitors with AMPC exhibited synergistic inhibitory effects in lung ADC cells. In addition, we demonstrated that the local secretion of TFF3 from lung ADC cells exerts paracrine effects on lung SCC cells, which is relevant in the adenosquamous carcinoma (ASC) subtype of NSCLC. Conclusion TFF3 is a crucial oncogene in NSCLC progression.The therapeutic inhibition of TFF3 alone or in combination with conventional MEK1/2 inhibitors are potential strategies in the treatment of NSCLC.

Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines

Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK + anaplastic large cell lymphoma.

Tripterine Induces Apoptosis of Human Acute Myelocytic Leukemic Cells Via Up-Regulating Fas/FasL and Down-Regulating NF-κB

Curcumin Induces Mitochondria Pathway Mediated Cell Apoptosis in A549 Lung Adenocarcinoma Cells.

Curcumin Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells Through a Reactive Oxygen Species-Dependent Mitochondrial Signaling Pathway.

Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma

Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling

Effect and Possible Mechanism of Tripterine on Inducing Apoptosis of Human Acute Myelocytic Leukemia HL-60 Cells.

Trifluoperazine exerts anti-osteosarcoma effect by inducing mitochondria-dependent apoptosis via AKT/TXNIP signaling pathway

Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.

Cytoskeleton disorganization during apoptosis induced by curcumin in A549 lung adenocarcinoma cells.

5-Alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives inhibit growth of lung cancer A549 cell by inducing apoptosis.

Atractylodin Induces Apoptosis and Inhibits the Migration of A549 Lung Cancer Cells by Regulating ROS-Mediated Signaling Pathways

A Novel Small-Molecule Inhibitor of Trefoil Factor 3 (TFF3) Potentiates MEK1/2 Inhibition in Lung Adenocarcinoma

Trifluoperazine an Antipsychotic Drug and Inhibitor of Mitochondrial Permeability Transition Protects Cytarabine and Ifosfamide-Induced Neurotoxicity

Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination

The Farnesyltransferase Inhibitor R115777 Up-Regulates the Expression of Death Receptor 5 and Enhances Trail-Induced Apoptosis in Human Lung Cancer Cells

PO-001 Therapeutic Inhibition of Trefoil Factor 3(TFF3) Decrease Oncogenic Behaviour in Non-Small Cell Lung Cancer (NSCLC)

Feiyanning Formula Induces Apoptosis of Lung Adenocarcinoma Cells by Activating the Mitochondrial Pathway

Inducing effect of recombinant mutant human TRAIL on apoptosis of lung cancer cells and its molecular mechanism

Tnf Alpha And Fas/Fasl Pathways Are Involved In 9-Methoxycamptothecin-Induced Apoptosis In Cancer Cells With Oxidative Stress And G(2)/M Cell Cycle Arrest